The anti-carcinogenesis effect demonstrated in 4-NQO-induced mouse models of oral mucosal carcinogenesis using CDK9 inhibitor could prove transformative if translated into clinical trials for preventing cancers in precancerous conditions. The gene discussed is CDK9; the disease is cancer.